The answer to your joint pain
|
|
|
|
The Genacol Group continuously invests in medical research to demonstrate the beneficial health effects of its products.
As such, two independent studies have scientifically confirmed that Genacol® helps reduce joint pain.
These two trials, one carried out at the University of Liège (200 subjects), and the other one at the Veterans Memorial Medical Center Institution (113 subjects), have shown positive results. With Genacol, a “statistically significant” beneficial effect with relation to pain was observed in the subjects: the best result that can be obtained during a clinical trial.
Both trials have confirmed the results of several other studies carried out in the past; revealing the beneficial effects of certain nutriments regarding joint health. Up to now, hydrolyzed collagen proves to be one of the most promising nutritional products.
Both trials have confirmed the results of several other studies carried out in the past revealing the beneficial effects of certain nutriments regarding joint health. To date, hydrolyzed collagen proves to be one of the most promising and revolutionary nutritional products.
Among others, a study carried out by researchers at the University of Kiel, of whom Dr. Steffen Oesser, Ph. D., associated to the Department of General and Thoracic Surgery, on the absorption rate and the levels of accumulation of bovine hydrolyzed collagen in the joints and its absorption in the organism, allowed to demonstrate that:
"The fast absorption of hydrolyzed collagen by the intestinal tract doubled the amount of nutriments accumulated in the cartilaginous tissue of the treated subjects, comparatively to the control group."
These results confirm that the hydrolyzed collagen reaches the tissues and is able to accumulate there in the long term. The following stage of this study consisted in determining if the hydrolyzed collagen could have a positive influence on joints after its accumulation. Thanks to a cell culture model, the researchers were able to demonstrate that:
"The presence of hydrolyzed collagen as the one found in Genacol® stimulated the production of new collagen. However, ordinary collagen (non hydrolyzed) did not have this stimulating effect."
According to Dr. Oesser, these results are crucial; as they allow us to comprefend that the hydrolyzed collagen not only reaches the target joint tissue, but its presence is capable of positively transforming the joint.
In an extremely significant three-month study intended to compare Genacol® with a liquid collagen and with a base collagen available on the market, Dr. Stephen Ho, Traumatologist, evaluated the effectiveness of these three products using five groups of subjects. Each group consisted of 30 subjects, all similar in size, weight, general health condition, age, and gender. The first group was given Genacol® over a 90 day period; the second group was given a liquid collagen; the third group received a collagen supplement sold in pharmacies; the fourth group was given a placebo composed of neutral ingredients; the fifth group (the control group) was given nothing at all.
A health check-up was carried out before and after the 90-day study to compare the groups. The group having taken Genacol® obtained the best results, followed by the group who took the liquid collagen, then the one who took the market collagen, then the placebo, and finally the control group.
The group who was administered Genacol® recorded considerable improvements regarding pain and skin quality. This group also recorded a considerable increase in its youth and vigor feelings. The group using a type II liquid collagen demonstrated improvements, but about 30% less favourable than the group having taken the unique matrix of Genacol®.
Group III, to whom a poultry-based market collagen was administered (predominantly type II), showed an improvement similar to the one of placebo group. Thus, this group showed only minor improvements. It is interesting to observe that different collagen by-products can show so many different results.
The placebo group, Group IV, which received non-bioactive capsules, recorded minor improvements, which can be attributed to psychological factors, given that the subjects expected results. This group was unaware that they were not being given any collagen. The control group, Group V, was not administered any form of collagen nor a placebo. This group also underwent a health check-up at the beginning and at the end of the study. A minor weight and body fat increase was observed for this group.
Dr. Ho concluded that:
"The Genacol® brand exclusive matrix using the AminoLock® sequence technology in its pure and dry state was superior to that of the liquid collagen or the one derived from poultry."
He also concluded that Genacol® considerably reduced pain when taken on a regular basis, resulted in a feeling of well-being and youth. He also observed that the group taking Genacol® had more restful and longer sleep periods, as well as more energy during waking hours. He would recommend Genacol® without hesitation to all the people wanting to reduce pain caused by a lack of collagen. Please note that neither Dr. Ho, nor his clinic received any form of financial compensation for this comparative study.
Complementary study by Dr. Patrick Price
Dr. Patrick Price, a health professional from Houston, Texas, conducted another major independent study on Genacol®. He studied three groups of patients that were essentially identical. Dr. Price observed that Genacol® produced an easily observable increase in energy, an arthritic pain relief, as well as an improvement in skin texture compared to the groups taking the placebo, which had only minor improvements. The control group, similar to the one in Dr. Ho’s study, did not show any changes. The results from the research studies by Dr. Stephen Ho and Dr. Patrick Price coincide with those from several other studies on collagen carried out across the world.
